Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Duitse aandelen Terug naar discussie overzicht

Munich RE

3 Posts
| Omlaag ↓
  1. Jebus4life 5 februari 2024 12:55
    Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft (kort Münchener Rück of in het Engels Munich Re) is een van 's werelds grootste herverzekeraars met hoofdzetel in München. De groep werd in 1880 gesticht door Carl Thieme, die 10 jaar later ook de verzekeraar Allianz AG stichtte. Het bedrijf telde bijna 40.000 medewerkers.

    De groep heeft de activiteiten verdeeld over drie bedrijfsonderdelen

    Munich Re is de merknaam voor de herverzekeringsactiviteiten van de groep. Het is de grootste herverzekeraar ter wereld.
    ERGO In dit bedrijfsonderdeel zijn de meeste reguliere verzekeringsactiviteiten gegroepeerd.
    MEAG is de vermogensbeheerder van de groep. Hier wordt voornamelijk het vermogen van de groep beheerd.

    De aandelen van Munich Re zijn beursgenoteerd waarvan de notering op Frankfurt de meest belangrijke is. Het maakt onderdeel uit van diverse aandelenindices, waaronder de DAX en de Euro Stoxx 50.
  2. Jebus4life 5 februari 2024 12:56
    Opvallend genoeg was hier geen topic over 1 van s'werelds belangrijkste verzekeraars. Geen flashy business natuurlijk, maar wel een enorme geldgenerator.

    De zaken gaan ook bijzonder goed, wat de verdubbeling van de koers de afgelopen 5 jaar verklaart:

    quote:

    Jebus4life schreef op 5 februari 2024 12:55:

    Munich Re reports preliminary Q3 net result of €1.2bn, sets new annual target

    Citing consistently good operational performance in all business segments, Munich Re has disclosed a preliminary net result for Q3 of ca. €1.2bn, as the firm remains “well positioned” to surpass the previous annual target of €4bn.

    Munich Re explained that in property-casualty reinsurance, it reported major losses that were slightly below the expected average. Meanwhile, in life and health reinsurance, the total technical result “once again exceeded pro-rata guidance.” Elsewhere, ERGO, the firm’s primary insurance arm, reported “consistently excellent business performance” that, due in part to higher losses from natural catastrophes, yielded a result that was slightly below the very high level seen in the two previous quarters.

    In its H1 results released in early August, Munich Re noted that ERGO grew considerably, with insurance revenue from insurance contracts issued climbing to €9.916bn (9.357bn last year). Including this preliminary disclosure, the result for the first nine months of the year now stands at €3.6bn. Thus, the firm has accordingly raised its annual guidance for 2023 to a net result of €4.5bn.
  3. Jebus4life 27 februari 2024 10:06
    Zeer nette resultaten weer bij MunichRE.

    quote:

    schreef:

    Munich Re, one of Europe’s largest reinsurers, has reported a net result of €4.6 billion for the 2023 financial year, which is above its revised €4.5 billion profit target announced in October, supported by a reinsurance result of €3.9 billion and an improved performance at ERGO.

    Despite beating the revised profit target and the initial target of €4 billion, total profit for the year did come in below the €5.3 billion reported in 2022, with a net result of just over €1 billion in Q4 2023, down from €1.1 billion in the prior year quarter. Group-wide, insurance revenue from insurance contracts issued rose to €57.9 billion from €55.4 billion, due in part to organic growth in the property and casualty (P&C) reinsurance segment and at ERGO, offset by currency translation effects.

    For 2023, the reinsurer’s return on equity (RoE) amounted to 15.7% compared with 20.2% a year earlier, as the technical result increased to €7.6 billion from €7.1 billion. At the same time, the investment result increased from €2.9 billion to €5.4 billion, while the operating result fell from €6.8 billion in 2022 to €5.7 billion in 2023.

    Looking forward, Munich Re has announced a target net result of €5 billion in 2024, with Group insurance revenue of €59 billion and the return on investment to surpass 2.8%.

    The company expects its reinsurance business to increase its insurance revenue to €39 billion and its contribution to the net result to €4.2 billion in 2024. The P&C combined ratio is expected to strengthen to 82%, while the L&H technical result is expected to improve to €1.45 billion in 2024. At ERGO, Munich Re expects to generate insurance revenue of €20 billion in 2024, with a higher profit contribution of €800 million.

    Joachim Wenning, Chair of the Board of Management, commented: “2023 was another successful year for Munich Re. We beat our annual profit target for the third consecutive time and delivered a strong performance across all business segments. Thanks to a broadly diversified business portfolio, Munich Re is well placed and fully on track to meet the targets specified in its Ambition 2025 strategy programme. With the exception of systemic risks – such as cyber and pandemic – our appetite for covering existential risks for people and enterprises is far from exhausted.”

    Christoph Jurecka, Chief Financial Officer, said: “All KPIs are near or even better than the Ambition 2025 targets at the end of 2023. Our financial strength makes it possible for our shareholders to participate in our success through a substantially higher dividend. They’ll also benefit from a new share buy-back that will likewise be substantially higher. And we remain ambitious, as we seek to boost our annual profit to €5bn this year.”


    [...]
3 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.848
AB InBev 2 5.308
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.580 47.069
ABO-Group 1 19
Acacia Pharma 9 24.692
Accell Group 151 4.129
Accentis 2 253
Accsys Technologies 22 9.035
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 160
ADMA Biologics 1 32
Adomos 1 126
AdUX 2 457
Adyen 13 16.614
Aedifica 2 832
Aegon 3.257 320.329
AFC Ajax 537 7.026
Affimed NV 2 5.778
ageas 5.843 109.785
Agfa-Gevaert 13 1.897
Ahold 3.536 74.015
Air France - KLM 1.024 34.390
AIRBUS 1 1
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.778
Alfen 13 17.257
Allfunds Group 3 1.236
Almunda Professionals (vh Novisource) 651 4.247
Alpha Pro Tech 1 17
Alphabet Inc. 1 341
Altice 106 51.196
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.771
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.821 240.483
AMG 965 126.557
AMS 3 73
Amsterdam Commodities 303 6.527
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 383
Antonov 22.632 153.605
Aperam 91 14.193
Apollo Alternative Assets 1 17
Apple 5 322
Arcadis 251 8.628
Arcelor Mittal 2.024 318.768
Archos 1 1
Arcona Property Fund 1 271
arGEN-X 15 9.183
Aroundtown SA 1 186
Arrowhead Research 5 9.312
Ascencio 1 20
ASIT biotech 2 697
ASMI 4.107 37.770
ASML 1.762 77.604
ASR Nederland 18 4.162
ATAI Life Sciences 1 7
Atenor Group 1 340
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 29 10.784
Axsome Therapeutics 1 177
Azelis Group 1 49
Azerion 7 2.681

Beleggingsideeën van onze partners

Macro & Bedrijfsagenda

  1. 22 mei

    1. Aalberts Q1-cijfers
    2. Prijzen bestaande koopwoningen april (NL)
    3. Consumenten- en producentenprijzen april (VK)
    4. Heijmans - Beleggersdag
    5. Hypotheekaanvragen - wekelijks (VS)
    6. Bestaande woningverkopen april (VS)
    7. Olievoorraden - wekelijks (VS)
    8. Federal Reserve notulen (VS) volitaliteit verwacht
    9. Nvidia Q1-cijfers
    10. Snowflake Q1-cijfers
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht